ChestLink

Oxipit

ChestLink is the first fully autonomous AI medical imaging product with a CE mark. ChestLink identifies CXRs with no abnormality and produces finalized patient reports without any intervention from the radiologist, reducing radiologist workload and enabling them to focus on cases with pathologies.

Product specifications

Information source: Vendor
Last updated: March 21, 2023

General
Product name	ChestLink
Company	Oxipit
Subspeciality	Chest
Modality	X-ray
Disease targeted	Algorithms support 75 different pathologies
Key-features	Autonomous healthy patients report generation
Suggested use	Without interference of a radiologist: AI-only diagnosis
Data characteristics
Population	Older than 18 years old
Input	PA or PA + LAT Digital Chest X Ray
Input format	DICOM
Output	Report for healthy patients
Output format	DICOM SR or HL7 message
Technology
Integration	Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	Automatically, right after the image acquisition
Processing time	10 - 60 seconds
Certification
CE	Certified, Class IIb , MDR
FDA	No or not yet
Market presence
On market since	03-2022
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of analyses
Evidence
Peer reviewed papers on performance	Autonomous Chest Radiograph Reporting Using AI: Estimation of Clinical Impact (read)
Non-peer reviewed papers on performance	USING ARTIFICIAL INTELLIGENCE TO DETECT CHEST X-RAYS WITH NO SIGNIFICANT FINDINGS IN A PRIMARY HEALTH CARE SETTING IN OULU, FINLAND (read)
Other relevant papers